CE vs EW · rev $10.28B vs P/E 47, rev $1.39B
Celanese Corporation (CE) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CE currently screens at market cap $5.92B. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CE and EW stock pages for the full models.
Not investment advice.